Search
PolyPid Ltd
PYPDAdd to Watchlist
5.020USD
-0.030-0.59%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
91.38MMarket Cap
LossP/E TTM
More Details of PolyPid Ltd Company
Polypid Ltd is a biopharmaceutical company at the clinical stage, based in Israel . The company focuses on the development, production and commercialization of new, locally administered therapies to improve surgical results. The main product is PLEX technology, which is located in the place of surgery and ensures controlled and continuous delivery of medicines.
PolyPid Ltd Info
Ticker SymbolPYPD
Company namePolyPid Ltd
IPO dateJun 26, 2020
CEOAkselbrad (Dikla Czaczkes)
Number of employees57
Security typeOrdinary Share
Fiscal year-endJun 26
Address18 Hasivim Street, P.O Box 7126
CityPETAH TIKVA
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryIsrael
Postal code4917002
Phone972747195700
Websitehttps://www.polypid.com
Ticker SymbolPYPD
IPO dateJun 26, 2020
CEOAkselbrad (Dikla Czaczkes)
Company Executives of PolyPid Ltd
Name
Name/Position
Position
Shareholding
Change
Dr. Yechezkel Barenholz, Ph.D.
Dr. Yechezkel Barenholz, Ph.D.
Independent Director
Independent Director
2.76K
--
Ms. Dikla Czaczkes Akselbrad
Ms. Dikla Czaczkes Akselbrad
Chief Executive Officer, Director
Chief Executive Officer, Director
934.00
--
Dr. Itzhak Krinsky, Ph.D.
Dr. Itzhak Krinsky, Ph.D.
Independent Director
Independent Director
833.00
--
Mr. Jacob Harel
Mr. Jacob Harel
Independent Chairman of the Board
Independent Chairman of the Board
467.00
--
Mr. Ori Warshavsky
Mr. Ori Warshavsky
Chief Operating Officer - US
Chief Operating Officer - US
267.00
--
Dr. Noam Emanuel, Ph.D.
Dr. Noam Emanuel, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Mrs. Anat Tsour Segal
Mrs. Anat Tsour Segal
Independent Director
Independent Director
--
--
Dr. Shaul Mukhtar, Ph.D.
Dr. Shaul Mukhtar, Ph.D.
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
--
--
Ms. Dalit Hazan
Ms. Dalit Hazan
Senior Vice President - Research and Development and Regulatory Affairs
Senior Vice President - Research and Development and Regulatory Affairs
--
--
Mr. Nir Dror
Mr. Nir Dror
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Yechezkel Barenholz, Ph.D.
Dr. Yechezkel Barenholz, Ph.D.
Independent Director
Independent Director
2.76K
--
Ms. Dikla Czaczkes Akselbrad
Ms. Dikla Czaczkes Akselbrad
Chief Executive Officer, Director
Chief Executive Officer, Director
934.00
--
Dr. Itzhak Krinsky, Ph.D.
Dr. Itzhak Krinsky, Ph.D.
Independent Director
Independent Director
833.00
--
Mr. Jacob Harel
Mr. Jacob Harel
Independent Chairman of the Board
Independent Chairman of the Board
467.00
--
Mr. Ori Warshavsky
Mr. Ori Warshavsky
Chief Operating Officer - US
Chief Operating Officer - US
267.00
--
Dr. Noam Emanuel, Ph.D.
Dr. Noam Emanuel, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
FAQs
Who are the top five shareholders of PolyPid Ltd?
The top five shareholders of PolyPid Ltd are: Dr. Yechezkel Barenholz, Ph.D.
How many institutions hold shares of PolyPid Ltd (PYPD)?
As of 2026Q1, 33 institutions hold shares of PolyPid Ltd, with a combined market value of approximately 6.41M, accounting for 33.61% of the total shares. Compared to 2025Q4, institutional shareholding has increased by 15623.00.